Form D · Other Banking and Financial Services

Prescient Bio-Analytics, LLC

Tallahassee, FL · CIK 0001563663

Offering snapshot reported May 7, 2014 · SEC filing

Reported sold: $1.55M
Investors reported: 47
Minimum accepted: $25K
First sale: Oct 1, 2009

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 7, 2014	Initial	$1,545,000	No comparison	47	SEC filing

Offering details

Securities: Equity, Debt
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-216903

Our securities attorney who is SEC qualified has amended our PPM through this offering. The first tranches began in 2009 with three investors. We amended the offering annually to where we are now in 12-month time frames.

There no finders fees. All investments go directly to Invoy Technologies, LLC. In item 14, the 2 unaccredited investors were excepted with near accreditation status because they wanted into the transaction. Otherwise, they would have been rejected.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Dr. Thom Park	None

Source: Form D, filed May 7, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Thomas R Park	Executive
Bruce Thomas	Executive

Issuer details

Industry: Other Banking and Financial Services (See others in industry)

Address:

223 South Gadsden Street 2nd Floor North
Tallahassee, FL, 32302